These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 31285227
1. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay. Vatanshenassan M, Arastehfar A, Boekhout T, Berman J, Lass-Flörl C, Sparbier K, Kostrzewa M. Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227 [Abstract] [Full Text] [Related]
2. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata. Vatanshenassan M, Boekhout T, Lass-Flörl C, Lackner M, Schubert S, Kostrzewa M, Sparbier K. J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820 [Abstract] [Full Text] [Related]
6. Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia. Berrio I, Maldonado N, De Bedout C, Arango K, Cano LE, Valencia Y, Jiménez-Ortigosa C, Perlin DS, Gómez BL, Robledo C, Robledo J, Grupo GERMEN. J Glob Antimicrob Resist; 2018 Jun; 13():254-260. PubMed ID: 29183771 [Abstract] [Full Text] [Related]
8. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait. Al-Baqsami ZF, Ahmad S, Khan Z. Sci Rep; 2020 Apr 10; 10(1):6238. PubMed ID: 32277126 [Abstract] [Full Text] [Related]
16. FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy. Costa-de-Oliveira S, Marcos Miranda I, Silva RM, Pinto E Silva A, Rocha R, Amorim A, Gonçalves Rodrigues A, Pina-Vaz C. Antimicrob Agents Chemother; 2011 Mar 10; 55(3):1312-4. PubMed ID: 21149621 [Abstract] [Full Text] [Related]
17. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov 10; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
18. Use of anidulafungin as a surrogate marker to predict susceptibility and resistance to caspofungin among 4,290 clinical isolates of Candida by using CLSI methods and interpretive criteria. Pfaller MA, Diekema DJ, Jones RN, Castanheira M. J Clin Microbiol; 2014 Sep 10; 52(9):3223-9. PubMed ID: 24951808 [Abstract] [Full Text] [Related]
19. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature. Arastehfar A, Daneshnia F, Salehi MR, Zarrinfar H, Khodavaisy S, Haas PJ, Roudbary M, Najafzadeh MJ, Zomorodian K, Charsizadeh A, Brouwer C, Pan W, Hagen F, Boekhout T. J Med Microbiol; 2019 May 10; 68(5):770-777. PubMed ID: 30924763 [Abstract] [Full Text] [Related]